Yen Ngo

2.9k total citations
52 papers, 2.1k citations indexed

About

Yen Ngo is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Yen Ngo has authored 52 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Epidemiology, 37 papers in Hepatology and 6 papers in Surgery. Recurrent topics in Yen Ngo's work include Liver Disease Diagnosis and Treatment (42 papers), Hepatitis C virus research (27 papers) and Hepatitis B Virus Studies (18 papers). Yen Ngo is often cited by papers focused on Liver Disease Diagnosis and Treatment (42 papers), Hepatitis C virus research (27 papers) and Hepatitis B Virus Studies (18 papers). Yen Ngo collaborates with scholars based in France, United States and Italy. Yen Ngo's co-authors include M. Munteanu, Thierry Poynard, Vlad Ratziu, Dominique Thabut, Pascal Lebray, Djamila Messous, Frédéric Charlotte, Thierry Poynard, Françoise Imbert‐Bismut and Julien Massard and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Yen Ngo

51 papers receiving 2.1k citations

Peers

Countries citing papers authored by Yen Ngo

Since Specialization

Citations

This map shows the geographic impact of Yen Ngo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yen Ngo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yen Ngo more than expected).

Fields of papers citing papers by Yen Ngo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yen Ngo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yen Ngo. The network helps show where Yen Ngo may publish in the future.

Co-authorship network of co-authors of Yen Ngo

This figure shows the co-authorship network connecting the top 25 collaborators of Yen Ngo. A scholar is included among the top collaborators of Yen Ngo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yen Ngo. Yen Ngo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Validation of the Performance of A1HPV6, a Triage Blood Test for the Early Diagnosis and Prognosis of SARS-CoV-2 Infection 2022 ·SHILAP Revista de lepidopterología ·Pauline Maisonnasse, Thierry Poynard, Mehdi Sakka, Sepideh Akhavan, Romain Marlin, Valentina Peta, Olivier Deckmyn, (unknown), Yen Ngo, Marika Rudler, Sylvie van der Werf, Stéphane Marot, Dominique Thabut, Harry Sokol, Chantal Housset, Alain Combes, Roger Le Grand, P. Cacoub	3
2	Baveno VI criteria as a prognostic factor for clinical complications in patients with compensated cirrhosis 2021 ·Digestive and Liver Disease ·(unknown), (unknown), (unknown), M. Munteanu, An Ngo, Yen Ngo, Thierry Poynard, Dominique Thabut, Marika Rudler	6
3	Input of serum haptoglobin fucosylation profile in the diagnosis of hepatocellular carcinoma in patients with non-cirrhotic liver disease 2020 ·Clinics and Research in Hepatology and Gastroenterology ·Valentina Peta, Jianhui Zhu, David M. Lubman, Samuel Huguet, (unknown), Gérard Bolbach, Gilles Clodic, (unknown), Yen Ngo, Raluca Pais, Chantal Housset, Keyvan Rezaï, Thierry Poynard	8
4	Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference 2016 ·Alimentary Pharmacology & Therapeutics ·M. Munteanu, Dina Tiniakos, Quentin M. Anstee, Frédéric Charlotte, Giulio Marchesini, Elisabetta Bugianesi, Michael Trauner, (unknown), Cláudia P. Oliveira, Christopher P. Day, Jean‐François Dufour, Stefano Bellentani, Yen Ngo, (unknown), Hugo Perazzo, Olivier Deckmyn, Pierre Bédossa, Vlad Ratziu, Thierry Poynard	69
5	Real-Time Shear Wave versus Transient Elastography for Predicting Fibrosis: Applicability, and Impact of Inflammation and Steatosis. A Non-Invasive Comparison 2016 ·PLoS ONE ·Thierry Poynard, Tam N. Pham, Hugo Perazzo, M. Munteanu, (unknown), (unknown), Yen Ngo, Luminita Bonyhay, (unknown), (unknown), An Ngo, Olivier Deckmyn, Dominique Thabut, Vlad Ratziu, Olivier Lucidarme, (unknown)	27
6	Awareness of the severity of liver disease re-examined using software-combined biomarkers of liver fibrosis and necroinflammatory activity 2015 ·BMJ Open ·Thierry Poynard, Olivier Deckmyn, M. Munteanu, Yen Ngo, Fabienne Drane, (unknown), Chantal Housset, Vlad Ratziu	8
7	Validation of AshTest as a Non-Invasive Alternative to Transjugular Liver Biopsy in Patients with Suspected Severe Acute Alcoholic Hepatitis 2015 ·PLoS ONE ·Marika Rudler, (unknown), Frédéric Charlotte, Philippe Cluzel, Yen Ngo, M. Munteanu, Pascal Lebray, Vlad Ratziu, Dominique Thabut, Thierry Poynard	12
8	Variability in definitions of transaminase upper limit of the normal impacts the APRI performance as a biomarker of fibrosis in patients with chronic hepatitis C: “APRI c’est fini ?” 2014 ·Clinics and Research in Hepatology and Gastroenterology ·Hugo Perazzo, Raluca Pais, M. Munteanu, Yen Ngo, Denis Monneret, Françoise Imbert‐Bismut, J. Moussalli, Pascal Lebray, Yves Benhamou, Dominique Thabut, Vlad Ratziu, (unknown), Thierry Poynard	5
9	Significant Variations in Elastometry Measurements Made Within Short-term in Patients With Chronic Liver Diseases 2014 ·Clinical Gastroenterology and Hepatology ·Fabio Nascimbeni, Pascal Lebray, Larysa Fedchuk, Cláudia P. Oliveira, Mário Reis Álvares‐da‐Silva, (unknown), Patrick Ingiliz, Yen Ngo, (unknown), M. Munteanu, Thierry Poynard, Vlad Ratziu, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	57
10	Liver fibrosis evaluation using real-time shear wave elastography: Applicability and diagnostic performance using methods without a gold standard 2013 ·Journal of Hepatology ·Thierry Poynard, M. Munteanu, (unknown), Hugo Perazzo, Yen Ngo, (unknown), Larysa Fedchuk, (unknown), Raluca Pais, Pascal Lebray, Marika Rudler, Dominique Thabut, Vlad Ratziu	146
11	Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: Proof of concept and first application in a large population 2012 ·Journal of Hepatology ·Thierry Poynard, M. Munteanu, Olivier Deckmyn, Yen Ngo, Fabienne Drane, (unknown), Chantal Housset, Vlad Ratziu, Françoise Imbert‐Bismut	65
12	Liver Biopsy Analysis Has a Low Level of Performance for Diagnosis of Intermediate Stages of Fibrosis 2012 ·Clinical Gastroenterology and Hepatology ·Thierry Poynard, Gilles Lenaour, Jean Christophe Vaillant, Frédérique Capron, M. Munteanu, Daniel Eyraud, Yen Ngo, (unknown), Vlad Ratziu, L Hannoun, Frédéric Charlotte	84
13	Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age 2011 ·BMC Gastroenterology ·Thierry Poynard, M. Munteanu, Olivier Deckmyn, Yen Ngo, Fabienne Drane, Djamila Messous, (unknown), Chantal Housset, Vlad Ratziu, Françoise Imbert‐Bismut	52
14	HCV-GenoFibrotest: A combination of viral, liver and genomic (IL28b, ITPA, UGT1A1) biomarkers for predicting treatment response in patients with chronic hepatitis C 2011 ·Clinics and Research in Hepatology and Gastroenterology ·Jean‐Marc Costa, (unknown), M. Munteanu, (unknown), Yen Ngo, Vincent Thibault, J. Moussalli, Vlad Ratziu, Yves Benhamou, (unknown), (unknown), Jean‐Dominique Poveda, Thierry Poynard	12
15	ActiTest accuracy for the assessment of histological activity grades in patients with chronic hepatitis C, an overview using Obuchowski measure 2010 ·Gastroentérologie Clinique et Biologique ·Thierry Poynard, M. Munteanu, Yen Ngo, Laurent Castéra, Philippe Halfon, Vlad Ratziu, Françoise Imbert‐Bismut, Dominique Thabut, Marc Bourlière, P. Cacoub, Djamila Messous, (unknown)	30
16	Anisometropic Amblyopia and Nasolacrimal Duct Obstruction 2009 ·Journal of Pediatric Ophthalmology & Strabismus ·John W. Simon, Yen Ngo, Eric S. Ahn, (unknown)	19
17	Impact of adefovir dipivoxil on liver fibrosis and activity assessed with biochemical markers (FibroTest–ActiTest) in patients infected by hepatitis B virus 2009 ·Journal of Viral Hepatitis ·Thierry Poynard, Yen Ngo, Patrick Marcellin, Stephanos J. Hadziyannis, Vlad Ratziu, Y. Benhamou, (unknown)	32
18	Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 update 2008 ·Gastroentérologie Clinique et Biologique ·Thierry Poynard, (unknown), (unknown), Yen Ngo, Françoise Imbert‐Bismut, Dominique Thabut, Djamila Messous, Julien Massard, Pascal Lebray, J. Moussalli, Y. Benhamou, Vlad Ratziu	34
19	An Accurate Definition of the Status of Inactive Hepatitis B Virus Carrier by a Combination of Biomarkers (FibroTest-ActiTest) and Viral Load 2008 ·PLoS ONE ·Yen Ngo, Yves Benhamou, Vincent Thibault, Patrick Ingiliz, M. Munteanu, Pascal Lebray, Dominique Thabut, Rachel Morra, Djamila Messous, Frédéric Charlotte, Françoise Imbert‐Bismut, Dominique Bonnefont‐Rousselot, J. Moussalli, Vlad Ratziu, Thierry Poynard	58
20	Risque d'hépatite C lié à des pratiques traditionnelles: une étude cas témoins à Ho-Chi-Minh-Ville, Vietnam 2007 ·Revue d Épidémiologie et de Santé Publique ·Yen Ngo, S. Maugat, (unknown), (unknown), Pascal Astagneau	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact